Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Change in Inventory (2020 - 2025)

GeneDx Holdings has reported Change in Inventory over the past 6 years, most recently at $3.4 million for Q4 2025.

  • Quarterly results put Change in Inventory at $3.4 million for Q4 2025, up 640.97% from a year ago — trailing twelve months through Dec 2025 was $3.4 million (up 32.92% YoY), and the annual figure for FY2025 was $3.4 million, up 32.92%.
  • Change in Inventory for Q4 2025 was $3.4 million at GeneDx Holdings, up from -$1.3 million in the prior quarter.
  • Over the last five years, Change in Inventory for WGSWW hit a ceiling of $9.8 million in Q1 2021 and a floor of -$7.6 million in Q4 2022.
  • Median Change in Inventory over the past 5 years was $465500.0 (2024), compared with a mean of $666000.0.
  • Peak annual rise in Change in Inventory hit 640.97% in 2025, while the deepest fall reached 379.25% in 2025.
  • GeneDx Holdings' Change in Inventory stood at $3.3 million in 2021, then tumbled by 330.67% to -$7.6 million in 2022, then surged by 96.14% to -$293000.0 in 2023, then surged by 254.95% to $454000.0 in 2024, then soared by 640.97% to $3.4 million in 2025.
  • The last three reported values for Change in Inventory were $3.4 million (Q4 2025), -$1.3 million (Q3 2025), and -$628000.0 (Q2 2025) per Business Quant data.